Bleeding in Patients With Atrial Fibrillation-Reply

JAMA. 2024 Sep 17;332(11):934. doi: 10.1001/jama.2024.13792.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Oral
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Diltiazem / administration & dosage
  • Diltiazem / adverse effects
  • Drug Interactions
  • Female
  • Hemorrhage* / chemically induced
  • Hemorrhage* / epidemiology
  • Humans
  • Male
  • Rivaroxaban / administration & dosage
  • Rivaroxaban / adverse effects
  • Sex Factors
  • Stroke / etiology
  • Stroke / prevention & control

Substances

  • Anticoagulants
  • Diltiazem
  • Rivaroxaban